Daktari Diagnostics
Daktari Diagnostics is a Cambridge, Massachusetts-based privately held medical device company founded in 2008 that manufactures diagnostic products for clinicians and patients, historically focused on point-of-care diagnostics for global health applications.
- Company typePrivate
- Founded2008
- HeadquartersCambridge, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Daktari Diagnostics firmographics
Firmographics- Name
- Daktari Diagnostics
- Website
- https://daktaridx.com
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 1–10 employees
- Short description
- Daktari Diagnostics is a Cambridge, Massachusetts-based privately held medical device company founded in 2008 that manufactures diagnostic products for clinicians and patients, historically focused on point-of-care diagnostics for global health applications.
- Ownership category
- akta.pro rank
Daktari Diagnostics industry classification
Industry- Product category
- Clinical Diagnostic Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI)
Keywords
Where Daktari Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Markets served
Daktari Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations
Daktari Diagnostics product offering
Product offeringCore offering
Daktari Diagnostics manufactures diagnostic medical products intended for clinicians and patients. The company develops point-of-care and clinical diagnostic devices that support infectious disease and other medical testing workflows. Its products are designed to enable rapid, accessible diagnostic testing at the point of care.
Differentiator
Problem solved
Functional benefit
Products and services
- Daktari Diagnostic Medical Products
Companies that use Daktari Diagnostics
Customer profileIdeal customer profiles1 record
Daktari Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Daktari Diagnostics competitors and assessment
Company assessmentDirect peers
- Hologic: Hologic's PANTHER system provides fully automated molecular POCT for HIV and other infectious diseases, positioning it as a direct competitor in decentralized molecular diagnostics markets where Daktari targeted sales.
- Abbott: Abbott markets the m-PIMA POC CD4 analyzer and a broad HIV viral-load/POCT portfolio, directly overlapping with Daktari's intended use case of HIV immune-status monitoring at point of care.
- Becton, Dickinson and Company (BD): BD developed and commercialized the FACSCount CD4 system and BD FACSDiscover, directly competing with Daktari's POC CD4 counting platform in HIV/AIDS patient monitoring in resource-limited settings.
- Cepheid (Danaher): Cepheid's GeneXpert platform dominates POCT molecular diagnostics for HIV viral load, TB, and other infectious diseases, competing with Daktari in the same LMIC POCT procurements and clinical workflows.
Broad incumbents
- bioMérieux: bioMérieux offers the BioFire and molecular microbiology menus used in clinical and infectious-disease diagnostics, making it a broad incumbent competing in adjacent POCT and centralized molecular spaces.
- Siemens Healthineers: Siemens Healthineers markets the ADVIA Centaur and Atellica immunoassay systems used in clinical labs, making it a broad incumbent competing in the diagnostic-testing infrastructure space where Daktari's products could be deployed.
- Roche Diagnostics: Roche operates the cobas platform for HIV viral load and a broad molecular diagnostics menu; as a large incumbent it competes broadly with any POC infectious-disease diagnostics provider including Daktari.
Others
- Mesa Labs: Mesa Labs operates in specialty diagnostics and life-science instrumentation; while not a direct competitor, it represents the type of small-cap diagnostics platform where residual Daktari IP could find an acquirer or partner.
Emerging players
- Trinity Biotech: Trinity Biotech supplies HIV diagnostic tests (including rapid tests) and hemoglobin A1c products, giving it partial overlap with Daktari's HIV-monitoring focus in resource-limited markets.
- QuidelOrtho: QuidelOrtho offers rapid immunoassay-based POCT diagnostics (e.g., Sofia platform) for infectious diseases, overlapping with Daktari's POCT positioning but with a different underlying assay technology.
Market position
Customer concentration
Daktari Diagnostics social profiles
Digital presenceDaktari Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Daktari Diagnostics leadership team
Management profileNumber of profiles
Profiles1 record
Daktari Diagnostics funding detail
Funding detailFunding overview
Funding rounds13 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Daktari Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Daktari Diagnostics
What does Daktari Diagnostics do?
Daktari Diagnostics manufactures diagnostic medical products intended for clinicians and patients. The company develops point-of-care and clinical diagnostic devices that support infectious disease and other medical testing workflows. Its products are designed to enable rapid, accessible diagnostic testing at the point of care.
When was Daktari Diagnostics founded?
Daktari Diagnostics was founded in 2008. It employs 1 to 10 people.
Where is Daktari Diagnostics based?
Daktari Diagnostics is headquartered in Cambridge, United States, in the North America region.
Who are Daktari Diagnostics's main competitors?
Direct peers on record are Hologic, Abbott, Becton, Dickinson and Company (BD) and Cepheid (Danaher). Broad incumbents are bioMérieux, Siemens Healthineers and Roche Diagnostics. Mesa Labs is listed as an others. Emerging players are Trinity Biotech and QuidelOrtho.
Does Daktari Diagnostics have an API?
No public API is recorded for Daktari Diagnostics.
What industry is Daktari Diagnostics in?
Daktari Diagnostics's product category is Clinical Diagnostic Devices. Its primary akta.pro industry code is HLAHAOAI, Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges). Its NAICS code is 339112 and its SIC code is 3841.